chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in injection site Muscle pain Fever Fatigue Abdominal pain Dizziness
2nd Moderna given 7 days before the recommended time between the 1st & 2nd dose
Day of vaccination- fatigue, shortness of breath,  chest tightness,  wheezing, hot flashes  Since date of vaccine- continuation of all these symptoms and exercise intolerance, increased shortness of breath and wheezing. Have had to  start use of albuterol inhaler and nebulizer, and Start Singulair asthma medication since the vaccine.
I sat down after vaccination and I felt sore right away up arm and up shoulder, went home, as driving, migraine began, vomiting, couldn't smell. Had to go to Dr and get shot for headache and nausea, vomited for 2 days, loss of appetite, bad body aches. After that I was able to eat and drink bland and it subsided.
This was a booster dose for this individual. Two day s after vaccine administration, he noticed a large swelling mid-line under his left axilla. It had generalized swelling but there was reportedly a palpable mass. I did not examine the patient and referred him to his private MD who felt it was a VAERS incident.
HYPOACTIVITY, WEAKNESS, UNBALANCE, GENERAL MALAISE, ARM REDNESS Narrative:
Resident began coughing then complained of abdominal pain and was taken to the Hospital. He began to vomit and breathed in. Had a heart attack
The afternoon following administration of vax pt became very irritable, unconsolable for several hrs that evening; pt was very feverish (temp not taken) & inject site very red & swollen; pt was improved next AM;
This is a spontaneous report received from COVAES. A non-contactable consumer (patient) reported a non-pregnant 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on the right arm on 13May2021 11:45AM (Lot number: EW0182)(at the age of 37 years old) as 1st dose, single dose for COVID-19 immunization. The vaccine was administered in a Workplace Clinic. Patient's medical history included hypothyroidism and prediabetes. The patient was diagnosed with COVID-19 prior to vaccination. Patient tested positive for COVID-19 prior to vaccination on an unspecified date. The patient has no known allergies. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE, 50 mcg tablet). On 15May2021 10:00 AM, the patient experienced rash/discoloration on groin lymph nodes, chills, dizziness, fever and extreme fatigue. The patient did not receive any treatment for the reported events. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the reported events were recovering. No follow-up attempts are possible. No further information is expected.
shortness of breath Hypoxia Pneumonia of both lungs due to infectious organism, unspecified part of lung History of COVID-19
Bells palsy symptoms starting on the evening of 12/4, presented to ED on 12/7. Giving steroids as treatment
head cold; lost her sensation of smell; exhausted; lost some of her tasting sensation; stuffy nose; Burning nose; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (lost some of her tasting sensation), NASAL CONGESTION (stuffy nose), NASAL DISCOMFORT (Burning nose), RHINORRHOEA (Running nose) and NASOPHARYNGITIS (head cold) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sore throat.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced AGEUSIA (lost some of her tasting sensation), NASAL CONGESTION (stuffy nose), NASAL DISCOMFORT (Burning nose) and RHINORRHOEA (Running nose). On 10-Jan-2021, the patient experienced NASOPHARYNGITIS (head cold), ANOSMIA (lost her sensation of smell) and FATIGUE (exhausted). At the time of the report, AGEUSIA (lost some of her tasting sensation) and ANOSMIA (lost her sensation of smell) outcome was unknown and NASAL CONGESTION (stuffy nose), NASAL DISCOMFORT (Burning nose), RHINORRHOEA (Running nose), NASOPHARYNGITIS (head cold) and FATIGUE (exhausted) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, SARS-CoV-2 test: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
J&J VACCINE MISTAKENLY ADMINISTERED TO 14 YEARS OLD; OFF LABEL USE; This spontaneous report received from a patient via a company representative concerned a 14 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced j&j vaccine mistakenly administered to 14 years old, and off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the j&j vaccine mistakenly administered to 14 years old and off label use was not reported. This report was non-serious.
pt recvd vax & was crying for 4 hrs; called MD; took pt into MD;
Pt reported 9/30/14 that a few hours after she got her Flu vaccine 9/29/14. Her throat became scratchy and her eyelid swelled. No hives, no respiratory, Distress. She took BENADRYL and her Sx resolved.
10/30/21 presents to ED with concerns for diarrhea, fatigue, chills and decreased appetite. PMH of ESRD s/p transplant 11 years ago, heart failure and HTN.
Pt is 54 yo female, s/p full Pfizer COVID vaccination: dose 1 on 1/13 and dose 2 on 2/3. Pt is an employee of this institution. On 8/7, she reports new onset cough, headache, sore throat, congestion/runny nose, and possible exposure to a COVID positive person. On 8/7, rapid COVID test results back positive. She receives casirivimab/imdevimab infusion on 8/10.
12/31/22 presents to ED for "cough, fever". PMHx of "SLE, RA, Sjogren's, MALT Lymphoma, Amyloidosis, Diastolic CHF, and Cystic Lung Disease"
Swelling and redness below injection site to the elbow with an itching sensation around the swelling which radiated down the arm to the wrist. The swelling was the size of my palm/fist. Onset of a mild headache. Applied ice to the swelling and took acetaminophen tablets prior to bed. The next AM the itching stopped with the swelling subsiding and the redness dissipated. The mild headache is continuing.
From telephone contact with patient, it was stated that she received a TD booster on 6/7/01. Patient had not received a booster for 12 years. That evening she was extremely fatigued. The next day, 6/8/01, she developed paresthesia in her extremities, which have continued. Patient has had a neurological work-up, which has showed nothing. From additional correspondence received on 10/15/01, this report has been upgraded to Serious, labeled. The patient was treated with MEDROL DOSE PAK without improvement. Her paresthesia intensified and now involves dysesthesia with burning pain. The patient was evaluated by a second neurologist who performed nerve conduction studies and EMG which returned normal. The patient has been on a variety of medications including PERCOCET during the month of August (discontinued), and imipramine, nortiptyline, and (currently) amitriptyline and lorazepam and (currently) AMBIEN and KLONONPIN. The patient has had some transient improvement on the latter medication.
A 7 year old received the 1st dose of Hep-A vaccine and 5 minutes later, while in the waiting room, he suddenly fainted. Blood pressure was normal. He was pale. He saw the blood coming on the PPD test site, 1 minute before fainting.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 46-year-old female patient who received RABAVERT. Co-suspect products included immunoglobulin human anti-rabies (HRIG) and prednisone for an unknown indication. The patient's past medical history included cat bite. Previously administered products included Rabies vaccine (received approximately 20 years ago), HRIG (received approximately 20 years ago) and RABAVERT with an associated reaction of adverse reaction (1st dose received on 27th October 2016). Concurrent medical conditions included asthma and animal bite. On 30th October 2016, the patient received the 2nd dose of RABAVERT and the 2nd dose of HRIG. In September 2016, the patient started prednisone at an unknown dose and frequency. On 30th October 2016, less than a day after receiving RABAVERT and not applicable after starting prednisone, the patient experienced headache, fatigue, cough, chest tightness and influenza-like symptoms. On 2nd November 2016, the patient experienced itchy legs. On an unknown date, the patient experienced drug interaction. On an unknown date, the outcome of the headache, fatigue, cough, chest tightness and itchy legs were recovering/resolving and the outcome of the influenza-like symptoms and drug interaction were unknown. The reporter considered the headache and fatigue to be related to RABAVERT. It was unknown if the reporter considered the cough, chest tightness, influenza-like symptoms and drug interaction to be related to RABAVERT. The reporter considered the itchy legs to be possibly related to RABAVERT. Additional details were provided as follows: The patient received the 2nd dose of RABAVERT on right deltoid. On 2nd November 2016 in the morning, 3 days after receiving RABAVERT, the patient experienced itching. The patient was underlying Asthma so was basically thinking the cough and chest tightness were related Asthma. The patient also noted flu like symptoms of headache and fatigue. The patient had itching of her thighs, as she had the HRIG shots in both thighs. On an unknown date, less than a week after receiving all vaccination, the patient experienced drug interaction. The patient recently experienced 2 puncture wounds on her left arm which was 2 and half inches up from her wrist. This case has been linked with case US2016GSK166662 as reported by same reporter.
Red rash over ears, elbows, knees and forearms. Rash on forearms was raised. Two Zyrtec taken two hours before vaccination to avoid rash, but it didn't work. Could have been a food allergy as I was at the kitchen table eating lunch from a restaurant at the time but I have never had a reaction to the food that I was eating  which I have had often over the years. All known allergies and sensitivities were avoided but the chance of cross contamination from the kitchen in the restaurant can't be ruled out. Having said this, this is a restaurant of choice because they are conscientious about food allergies and I have never had a reaction from their food ever in many years of eating there.
Report side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (report side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (report side effects). At the time of the report, VACCINATION COMPLICATION (report side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications and treatment information was not provided.
Pt was observed post Covid-19 immunization for 30 minutes based on pre-vaccination screening .  During the observation period, she experienced an adverse reaction with the following symptoms:  dizziness and dry mouth.   Assessment : Time of assessment 10:54. Alert and oriented, Anxious and Felt wobbly, headache. Completed observation period of 30 minutes, stood up to go home, felt dizzy, dry mouth, wobbly 1054 BP 128/85 pulse 99; 1102 BP 139/80 Pulse 93, taken from observation area  Via w/c to stretcher in hall way, given water, continues to feel dizzy  1110BP 143/96 Pulse 91 pulse ox 98, 1118 Complaints of headache         BP 144/101 Pulse 89 pulse ox 98 , 1124 EMS called continues to feel dizzy with headache, 1137 EMS arrived BP 143/84 pulse ox 96 1141 Complaints of severe headache dizziness BP 135/84, sitting BP 149/92 pulse 96 pulse ox 97 became dizzy standing for BP unable to complete.  1145 am transported to ER per patient request via EMS, purse given to mother   Actions taken:  Vitals sign taken  EMS called at  1124. VAERS form obtained and completed  Hand off to EMS upon arrival at 1137.   There were no vitals filed for this visit.   Medications administered: No medication administered.   Disposition:Patient evaluated and transferred to the hospital for further evaluation and care. Time of transport: 1145.
Major Rash to the lower legs and swelling in his ankles - Had to go to emergency  I have pictures but this site does not allow the upload of a doc
No adverse event occurred. The Janssen COVID-19 vaccine was inadvertently administered to a sixteen year old. The owner of a small local masonry company had arranged for and helped schedule COVID vaccines for his employees, which included  two of his children. We had originally discussed using the Pfizer vaccine for which his daughter was old enough. The day they were scheduled to receive the vaccine, we received our first shipment of Janssen vaccine. The company owner thought that would be a better choice for his employees due to it being a one dose vaccine. The masonry business is being to pick up rapidly now that it is warming up and concrete projects are starting and it would be difficult for them to return in 3 weeks for a second dose. The group decided to go with the Janssen vaccine .They arrived as a group in the evening and were processed for vaccination. We had been doing Pfizer vaccine all day and the minimum birthdate for vaccination was set to 4/9/2005, or 16 years old. We had just begun to do an evening of Janssen vaccine at 5:00pm and did not change the date to 4/9/2003, or 18 years old. This was the first time we had Janssen vaccine in our pharmacy. Patient was inadvertently vaccinated with the Janssen vaccine along with the rest of the group. The administration error was discovered later during the claim billing process.
Loses function of legs for at least 30 seconds, cannot stand up or hold weight  First even 4/11/2006 Second event 5/17/2006 Took to neurologist-all test negative These events only seem to occur after vaccines. I am including his vaccine history. I do not know if he had reactions prior to the 18 month vaccines, as he really wouldn't have been walking very long, and it is always his legs that are affected. I've tried to discuss with his doctor the possibility he could be allergic to a "filler" or something in the vaccine. She won't even entertain the idea. She says go the the neurologist. I am very frustrated. I spend hundreds of dollars at the neurologist doing tests, etc and they don't find anything wrong. As I mentioned this only seems to happen to him during the month that follows the vaccine, no other time, which really makes me think there is a connection.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX, lot number M036292 with expiration date 17-AUG-2018, (dose, route and anatomical location were not reported) for prophylaxis. Other suspect therapy included sterile diluent(STERILE DILUENT), (dose, route, anatomical location, lot number and expiration date were not reported) for prophylaxis. The vaccine was exposed to temperature of 24.4F (Fahrenheit) during 3 hours and 21 minutes. There was no previous temperature excursion. Data logger was filled. No adverse effect was reported. Additional information has been requested.
little bit of soreness in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 84 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date Mar2021 (Batch/Lot number: unknown) at the age of 84 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Pernicious anaemia" (ongoing), notes: diagnosed over 40 years ago. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "little bit of soreness in the arm".  Additional Information: The patient was not related to any study or programme. Vaccination facility was reported as police combination building. Family Medical History Relevant to AE(s) was reported as none. She had spoken with her local health department where she got the first two Pfizer covid vaccine shots back in Mar. With the first dose she had no problems, aside from a little bit of soreness in the arm. First dose of Pfizer covid vaccine: Mar2021, in the morning around 10:00 or 11:00. She does not have the exact date or her vaccination card handy to provide lot number. She might had got the first dose in her right arm. No AE(s) following prior to vaccination. The patient was neither received any other additional vaccine within 4 weeks prior to vaccination nor on the same date of Covid-19 vaccination. No relevant tests or investigation assessment were reported. Events did not resulted in emergency room/physician office visit.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient presented to pharmacy informing pharmacist that her arm has been itching for approximately 2 weeks and after injection it bruised some and was red.
Initial and follow-up information has been received from a nurse concerning a 7 year old male with an allergy to AUGMENTIN who on 11-MAY-2000 was vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Oka/Merck) (lot no. was reported as 1457T). There was no concomitant medication. On 24-OCT-2006 the patient was seen in the office with pain in right inguinal area and was diagnosed with shingles. The patient was treated with acyclovir. The following day the patient had lesions from his right knee to his foot and pain and difficulty walking on the right leg. On 25-OCT-2006 the patient was admitted to the hospital for twenty four hours. The patient was diagnosed with right leg pain, fever, shingles and limp to right leg. The patient was treated with intravenous fluids (unknown) for dehydration. The patient was seen by an orthopedic doctor. Blood tests were performed and results not reported. Magnetic resonance imaging for right thigh and right lower leg, bone scan and X-ray of lower extremity were all negative. Dermatologist saw the patient and diagnosed the patient with shingles. The patient improved in twenty four hours with acyclovir. In 2006, the patient was recovered. There were no lesions present. The reporter considered pain in right inguinal area, right leg pain, limp to right leg, had a couple of blisters, fever, shingles and dehydration to be disabling, caused a prolonged hospitalization and other important medical events. Additional information has been requested.
Patient was accidentally administered with VAXELIS today even though he did not need it; This spontaneous safety report, with reference number 2023SA208212 (Inquiry number 01683246), was received by a partner on 07-JUL-2023 and forwarded to company on 10-JUL-2023, from a HCP.   The causal relationship between Vaxelis and the reported event "Patient was accidentally administered with VAXELIS today even though he did not need it" was assessed as not applicable due to the nature of the event.  Further information is expected.  Significant Follow-up information was received by the partner on 02-AUG-2023 and forwarded to company on the same day, from a physician. This case is maintained as non-serious.  The causal relationship between VAXELIS and the reported event of "Patient was accidentally administered with VAXELIS today even though he did not need it" is not applicable."  No further information is expected.
Information has been received from a registered nurse (R.N.) referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with doses of improperly stored PROQUAD (lot # L009210 expiration date 17-SEP-2016; dose and route unspecified), which were previously exposed to temperature excursion of 9.6 Celsius degree (C) for 1 hour and 45 minutes because of a data logger. The currently temperature frame was reported as -14.3 (C) for 1 hour and 34 minutes. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
2 wks post/vax, right deltoid, 2cm abscess formed that required I & D. Patient was ill and nauseous. Grew out Staph on culture.
hive (size of quarter) appeared almost immediately just above site of MMR inject; surrounded by erythema; no breathing problems appeared in next half hr; no treatment;
Feeling Miserable; Covid-19; Shoulder Soreness; This spontaneous case was reported by a health care professional and describes the occurrence of FEELING ABNORMAL (Feeling Miserable), COVID-19 (Covid-19) and ARTHRALGIA (Shoulder Soreness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unk and unk) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling Miserable), COVID-19 (Covid-19) and ARTHRALGIA (Shoulder Soreness). At the time of the report, FEELING ABNORMAL (Feeling Miserable) outcome was unknown and COVID-19 (Covid-19) and ARTHRALGIA (Shoulder Soreness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication and treatment  medication was provided by the reporter.
Vaccine 12/30/2020 Screening PCR done 12/31/2020 Symptoms 1/1/2021 COVID test result came back positive 1/2/2021 Deceased 1/4/2021